Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes
- 1 February 1983
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 728 (2), 171-178
- https://doi.org/10.1016/0005-2736(83)90468-6
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prostaglandin F2α antagonizes thromboxane A2-induced human platelet aggregationProstaglandins, 1982
- Characterization of the Platelet Prostaglandin D2 ReceptorJCI Insight, 1979
- Azaprostanoic acid derivatives. Inhibitors of arachidonic acid induced platelet aggregationJournal of Medicinal Chemistry, 1979
- Selective Binding Site for [3H]Prostacyclin on PlateletsJCI Insight, 1979
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- The synthesis of prostaglandin endoperoxide analogsTetrahedron Letters, 1975
- An endoperoxide aggregator (LASS), formed in platelets in response to thrombotic stimuli-purification, identification and unique biological significanceProstaglandins, 1974
- Prostaglandin D2 inhibits the aggregation of human plateletsThrombosis Research, 1974
- Properties of graphical representations of multiple classes of binding sitesBiochemistry, 1971
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949